Best Targeted Therapy Treatment Hospitals Worldwide

With advanced oncology infrastructure, Primus Super Speciality Hospital offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2001, the NABH accredited hospital is located in Delhi, India, and has 250 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.

At VM Medical Park Ankara, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The JCI accredited facility has been functioning since 2014 and is located in Ankara, Turkey. The hospital has 327 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

Medical Park Tokat Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The JCI accredited hospital was established in 2015 in Tokat, Turkey and has 157 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

VM Medical Park Samsun Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The JCI accredited hospital was established in 2017 in Samsun, Turkey and has 300 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

At Apollo Hospitals, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 1988, the JCI accredited hospital is located in Hyderabad, India, and has 550 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.

The state-of-the-art Targeted Therapy services offered by Sterling Wockhardt Hospital, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Mumbai, India. Founded in 2001, the NABL accredited hospital has 225 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

The state-of-the-art Targeted Therapy services offered by Star Hospitals, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Hyderabad, India. Founded in 2008, the NABH, NABL accredited hospital has 435 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

With advanced oncology infrastructure, Millennium Cancer Center offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2004, the accredited hospital is located in Gurgaon, India, and has 100 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.

At The London Clinic, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in , the JCI accredited hospital is located in London, United Kingdom, and has 234 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.

The state-of-the-art Targeted Therapy services offered by Farrer Park Hospital, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Singapore, Singapore. Founded in 2016, the accredited hospital has 220 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

With advanced oncology infrastructure, Special Neolife Medical Center offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2010, the JCI accredited hospital is located in Istanbul, Turkey, and it has adequate bed capacity.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.

At Ekol, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The ISO accredited facility has been functioning since 2000 and is located in Izmir, Turkey. The hospital it has adequate bed capacity and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

At Arab Medical Center, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The JCI accredited facility has been functioning since 1997 and is located in Amman, Jordan. The hospital has 243 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

At Max Super Speciality Hospital, Saket, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 2006, the JCI, NABH accredited hospital is located in Delhi, India, and has 539 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.

At Fortis Hospital, Mulund, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The JCI, NABH accredited facility has been functioning since 2002 and is located in Mumbai, India. The hospital has 315 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.